Stock Price
140.66
Daily Change
-0.37 -0.26%
Monthly
-7.19%
Yearly
-43.25%
Q1 Forecast
138.07

CSL reported $482.13M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Arca Biopharma USD 37K 0 Mar/2025
aTyr Pharma USD 97.99M 97.9M Sep/2025
Bio Path USD 8K 2K Mar/2025
Brainstorm Cell Therapeutics USD 15K 1000 Mar/2025
Cara Therapeutics USD 2K 3K Mar/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 59K 934K Sep/2023
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Immunic USD 8K 4K Jun/2024
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Minerva Neurosciences USD 1000 0 Sep/2024
TherapeuticsMD USD 11K 0 Sep/2023